Antifibrotics and wound healing in glaucoma surgery

Related Experiment Videos

Paul J Lama1, Robert D Fechtner

  • 1Glaucoma Division, New Jersey Medical School, Newark 07103, USA.

Insights

Glaucoma surgery success depends on controlling wound healing. This review examines anti-fibrotic agents like 5-fluorouracil and mitomycin C, and steroids to improve surgical outcomes and reduce complications.

Area of Science:

  • Ophthalmology
  • Surgical Science
  • Pharmacology

Background:

  • Glaucoma filtration surgery is essential when medical and laser therapies fail to manage intraocular pressure.
  • Surgical success hinges on modulating the wound-healing response to maintain the new filtration pathway's patency.

Purpose of the Study:

  • To review the wound-healing pathway in glaucoma surgery.
  • To analyze pharmacologic interventions used to interrupt wound healing.
  • To evaluate agents like steroids, 5-fluorouracil, and mitomycin C for enhancing surgical success and managing complications.

Main Methods:

  • Comprehensive review of published literature on wound healing in glaucoma surgery.
  • Critique and interpretation of clinical and experimental studies using anti-fibrotic agents and steroids.
  • Analysis of agent efficacy, complications, and future therapeutic directions.

Main Results:

  • Steroids, 5-fluorouracil, and mitomycin C have been employed to inhibit wound healing and improve filtration surgery success rates.
  • These agents are associated with specific complications that require careful consideration and management.
  • The effectiveness and safety profiles of these interventions vary, necessitating a balanced approach.

Conclusions:

  • Pharmacologic modulation of wound healing is critical for successful glaucoma filtration surgery.
  • Careful selection and application of anti-fibrotic agents and steroids are necessary to balance efficacy and safety.
  • Emerging agents targeting pathways like anti-transforming growth factor beta 2 offer future potential for improved outcomes.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...